Intravenous immunoglobulins--understanding properties and mechanisms.
about
Immunotherapy of systemic sclerosisThe Production Processes and Biological Effects of Intravenous ImmunoglobulinRhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME)Diagnosis and management of paraneoplastic neurologic disordersImmune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodiesIntravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection.Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin.Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europePassively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis.Optimal attenuation of experimental autoimmune encephalomyelitis by intravenous immunoglobulin requires an intact interleukin-11 receptor.Adequate patient's outcome achieved with short immunoglobulin replacement intervals in severe antibody deficiencies.Multifarious roles of sialic acids in immunity.Large-scale in vitro expansion of polyclonal human switched-memory B lymphocytes.Induced expression of FcγRIIIa (CD16a) on CD4+ T cells triggers generation of IFN-γhigh subset.Intravenous immunoglobulin (IVIg) dampens neuronal toll-like receptor-mediated responses in ischemia.Serum protein electrophoresis under effective control of HIV-1 disease progression.IgG Conformer's Binding to Amyloidogenic Aggregates.Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspectiveThe case for immunomodulatory approaches in treating HSV encephalitis.Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trialChallenges with sensitized recipients in pediatric heart transplantation.Tregitope peptides: the active pharmaceutical ingredient of IVIG?Intravenous immunoglobulin protects neurons against amyloid beta-peptide toxicity and ischemic stroke by attenuating multiple cell death pathways.Agents to reduce cytokine storm.Disease-modifying effect of intravenous immunoglobulin in an experimental model of epilepsy.Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients.Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy.Mechanisms of action of intravenous immunoglobulin in inflammatory muscle disease.Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation.The role of sialic acid as a modulator of the anti-inflammatory activity of IgG.Immunopathological events initiated and maintained by pathogenic IgG autoantibodies in an experimental autoimmune kidney disease.Immunoglobulins in adult sepsis and septic shock.Subcutaneous immunoglobulins: product characteristics and their role in primary immunodeficiency disease.Alzheimers disease: review of emerging treatment role for intravenous immunoglobulins.Intravenous immunoglobulin-mediated immunosuppression and the development of an IVIG substitute.Mechanisms and potential therapeutic targets in allergic inflammation: recent insights.B-cell modulation of dendritic-cell function: signals from the far side.Polyvalent immunoglobulins: challenges and perspectivesThe expanding role of therapeutic antibodies.Clinical applications of immunoglobulin in neuromuscular diseases: focus on inflammatory myopathies.
P2860
Q24634395-DA67C464-2942-4BB5-A08F-611F05F330FEQ26752540-CAA778B3-29D3-4997-9945-C1E91724DEA1Q26824798-1AC4AAFB-404D-46D1-9E8F-F70C3EDF2FD7Q26853598-3E59E03F-36B2-4721-BF35-85AA6F24B241Q28069362-BEF2D7C1-3650-4472-BEF1-0D7BD2488A88Q30401056-5E9311B9-A82B-45D1-8E03-86B704712D00Q33399238-664F9EA7-F546-430D-A424-34397F33733FQ33419638-21E51259-59F0-4381-B764-810B5C15D108Q33926907-167AD597-60EE-4A42-BFCF-BD639F9FF33CQ33981829-1A9DCA6C-B219-4508-8D3D-E5ADCE2F53DCQ34196132-FBD5C083-34C4-4866-9176-640DDFC2C643Q34270155-A1366AA0-8206-4C38-A086-1030F55DE549Q34532604-5CFC2133-1D0B-4F62-B532-85497C5E759FQ35104018-DF6B41C4-F14F-4DB2-92A0-9E7760FCDDDAQ35538065-F2D8DD35-4CD3-45F6-A74A-6A47BE9A42D9Q35728932-34AB0761-36DD-46E7-A495-F00F1E858978Q35772596-F5B999CE-12DD-4E38-BFA6-4518570D869FQ36646072-75BF510B-77D5-45EF-8F60-5E7B99ED0B23Q37091308-0325B0F7-3814-4F82-A4E7-31E623F737CAQ37113332-E65E69A4-3028-427F-9BE1-B6196491333EQ37446864-F45818AD-A4FB-4034-9973-73F1DE41D12FQ37456938-30463E15-EEA4-4C24-8522-C95EE9B0C34AQ37487547-ED357B6B-0A58-4817-B561-AC27191EDCFBQ37577684-9267A165-4AE4-42C9-A780-8A1DAB01AC37Q37578846-F6DA95F5-F499-43B3-A774-B994E2AC0EBDQ37827197-C90F51A1-FFA6-416B-9294-804D04CAFB2DQ37861870-3C648D3A-D7E7-4DAC-A46C-9CD9AE86416FQ37866685-BB180DF0-439F-4D7E-8DD3-1F2A1DFF558EQ37877263-FB5585B9-395B-4DB2-9129-A745BEC1CBB1Q37995919-6B443888-82AE-46CF-9708-FCD6915DE8BFQ38027890-ECA04DF6-B8BD-460D-99BF-9B4E941628D6Q38034107-EC4F32B8-B850-4CC5-B065-23776C32C9D3Q38065205-2FD9EA88-2451-4D81-842C-777B6492E9CFQ38122150-C21F8DA0-5CD4-46C1-BC7C-486486703D42Q38133405-1C6FD671-D0A8-4479-A52F-FF723738A55DQ38161574-755CC950-861A-487A-8104-A6A6B07D1CB1Q38168787-F4A4FA88-54B6-48FD-941B-29F812A69EB1Q38170873-FA3BEBAC-B87C-4230-AB21-98833AED47CEQ38182645-CB296987-5C28-42FB-BC92-353269E0D25DQ38281407-6048460B-0D4D-4D5C-AB21-E140E62E0CAC
P2860
Intravenous immunoglobulins--understanding properties and mechanisms.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intravenous immunoglobulins--understanding properties and mechanisms.
@en
Intravenous immunoglobulins--understanding properties and mechanisms.
@nl
type
label
Intravenous immunoglobulins--understanding properties and mechanisms.
@en
Intravenous immunoglobulins--understanding properties and mechanisms.
@nl
prefLabel
Intravenous immunoglobulins--understanding properties and mechanisms.
@en
Intravenous immunoglobulins--understanding properties and mechanisms.
@nl
P2093
P2860
P50
P1476
Intravenous immunoglobulins--understanding properties and mechanisms.
@en
P2093
J V Ravetch
S Miescher
S V Kaveri
T W Kuijpers
P2860
P356
10.1111/J.1365-2249.2009.04022.X
P478
158 Suppl 1
P577
2009-12-01T00:00:00Z